Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial
5/7/2013 11:01:34 AM
More...
|
Aileron Therapeutics Presents New Preclinical Data on Stapled Peptide Inhibitor of Cancer Transcription Factor HIF-1a at American Association for Cancer Research Annual Meeting
4/10/2013 6:59:16 AM
More...
|
Aileron Therapeutics Presents New Data on Stapled Peptide Oncology Program at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics
11/7/2012 9:20:19 AM
More...
|
Aileron Therapeutics to Present at Upcoming Scientific Conferences and Industry Events
10/31/2012 7:39:13 AM
More...
|
Aileron Therapeutics Unveils New Therapeutic Drug Program; Appoints Hubert C. Chen, M.D., to Vice President of Clinical Development
9/6/2012 10:18:00 AM
More...
|
Aileron Therapeutics, Roche (RHHBY) Expand $1.1 Billion Drug Collaboration
11/16/2011 6:21:25 AM
More...
|
Aileron Therapeutics to Present at Several Upcoming Peptide Drug Discovery Conferences
5/25/2011 10:28:08 AM
More...
|
Aileron Therapeutics Appoints Veterans of Life Sciences Industry and Wall Street to its BOD; Nobel Laureate and Venerated Drug Developers Join Company’s SAB
5/11/2011 11:24:22 AM
More...
|
Aileron Therapeutics Appoints Experienced Drug Developer, Anthony M. Manning, Ph.D., to Senior Vice President of Research and Preclinical Development
4/12/2011 8:50:20 AM
More...
|
The Scripps Research Institute and Aileron Therapeutics Enter Exclusive Worldwide Agreement to Utilize "Click" Chemistry for the Development of Stabilized Peptide and Protein Therapeutics
11/30/2010 9:19:20 AM
More...
|
|